Predictors of endoscopic transsphenoidal surgery outcome in acromegaly: Patient and tumor characteristics evaluated by magnetic resonance imaging

Pituitary

Volumn 16, Issue 2, 2013, Pages 158-167

  Van Bunderen, Christa C ^a   Van Varsseveld, Nadège C ^a   Baayen, Johannes C ^a   Van Furth, Wouter R ^b   Aliaga, Esther Sanchez ^a   Hazewinkel, Marieke J ^a   Majoie, Charles B L M ^b   Freling, Nicole J M ^b   Lips, Paul ^a   Fliers, Eric ^b   Bisschop, Peter H ^b   Drent, Madeleine L ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Acromegaly; GH secreting pituitary adenoma; MRI; Transsphenoidal surgery; Tumor characteristics

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACCURACY; ACROMEGALY; ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; CAVERNOUS SINUS; CEREBROSPINAL FLUID OTORRHEA; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES INSIPIDUS; ENDOSCOPIC SURGERY; FEMALE; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HYPOGONADISM; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; INFRASELLAR EXTENSION; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARASELLAR EXTENSION; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIOTHERAPY; REOPERATION; RETROSPECTIVE STUDY; SEX DIFFERENCE; SPHENOID SINUS; TRANSSPHENOIDAL HYPOPHYSECTOMY; TUMOR INVASION; TUMOR RECURRENCE; TUMOR REGRESSION; TUMOR VOLUME; UNIVERSITY HOSPITAL;

ACROMEGALY; ADULT; AGED; ENDOSCOPY; FEMALE; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84878760532     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-012-0395-7     Document Type: Article

References (39)

1. Melmed S (2009) Acromegaly pathogenesis and treatment. J Clin Invest 119:3189-3202
2. Scacchi M, Cavagnini F (2006) Acromegaly. Pituitary 9:297-303
3. Ayuk J, Sheppard MC (2008) Does acromegaly enhance mortality? Rev Endocr Metab Disord 9:33-39
4. Laws ER (2008) Surgery for acromegaly: evolution of the techniques and outcomes. Rev Endocr Metab Disord 9:67-70
5. Cushing H III (1909) Partial hypophysectomy for acromegaly: with remarks on the function of the hypophysis. Ann Surg 50:1002-1017
6. Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP (2008) Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab 93:61-67
7. Nomikos P, Buchfelder M, Fahlbusch R (2005) The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'. Eur J Endocrinol 152:379-387
8. Bates PR, Carson MN, Trainer PJ, Wass JAH (2008) Wide variation in surgical outcomes for acromegaly in the UK. Clin Endocrinol (Oxf) 68:136-142
9. Besser GM, Burman P, Daly AF (2005) Predictors and rates of treatment-resistant tumor growth in acromegaly. Eur J Endocrinol 153:187-193
10. Colao A, Attanasio R, Pivonello R, Cappabianca P, Cavallo LM, Lasio G, Lodrini A, Lombardi G, Cozzi R (2006) Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J Clin Endocrinol Metab 91:85-92
11. Petrossians P, Borges-Martins L, Espinoza C, Daly A, Betea D, Valdes-Socin H, Stevenaert A, Chanson P, Beckers A (2005) Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs. Eur J Endocrinol 152:61-66
12. Melmed S, Colao A, Barkan A, Molitch M, Grossman AB, Kleinberg D, Clemmons D, Chanson P, Laws E, Schlechte J, Vance ML, Ho K, Giustina A (2009) Guidelines for acromegaly management: an update. J Clin Endocrinol Metab 94:1509-1517
13. Guy RL, Benn JJ, Ayers AB, Bingham JB, Lowy C, Cox TC, Sonksen PH (1991) A comparison of CT and MRI in the assessment of the pituitary and parasellar region. Clin Radiol 43:156-161
14. Cottier JP, Destrieux C, Brunereau L, Bertrand P, Moreau L, Jan M, Herbreteau D (2000) Cavernous sinus invasion by pituitary adenoma: MR imaging. Radiology 215:463-469
15. Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610-617
16. Hardy J (1973) Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT (eds) Diagnosis and treatment of pituitary tumors. Exerpta Medica, Amsterdam, pp 179-198
17. Wilson CB (1979) Neurosurgical management of large and invasive pituitary tumors. In: Tindal GT, Collins WF (eds) Clinical management of pituitary disorders. Raven Press, New York, pp 335-342
18. Bourdelot A, Coste J, Hazebroucq V, Gaillard S, Cazabat L, Bertagna X, Bertherat J (2004) Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly. Eur J Endocrinol 150:763-771
19. Endert E, van Rooden M, Fliers E, Prummel MF, Wiersinga WM (2006) Establishment of reference values for endocrine tests - part V: acromegaly. Neth J Med 64:230-235
20. Royston P, Moons KGM, Altman DG, Vergouwe Y (2009) Prognosis and prognostic research: developing a prognostic model. BMJ 338:b604
21. Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB (1998) Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 83:3411-3418
22. Sheaves R, Jenkins P, Blackburn P, Huneidi AH, Afshar F, Medbak S, Grossman AB, Besser GM, Wass JA (1996) Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure. Clin Endocrinol (Oxf) 45:407-413
23. Lissett CA, Peacey SR, Laing I, Tetlow L, Davis JR, Shalet SM (1998) The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma. Clin Endocrinol (Oxf) 49:653-657
24. Vieira JOJ, Cukiert A, Liberman B (2006) Evaluation of magnetic resonance imaging criteria for cavernous sinus invasion in patients with pituitary adenomas: logistic regression analysis and correlation with surgical findings. Surg Neurol 65:130-135
25. Carlsen SM, Lund-Johansen M, Schreiner T, Aanderud S, Johannesen O, Svartberg J, Cooper JG, Hald JK, Fougner SL, Bollerslev J (2008) Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial. J Clin Endocrinol Metab 93:2984-2990
26. Frank G, Pasquini E (2006) Endoscopic endonasal cavernous sinus surgery, with special reference to pituitary adenomas. Front Horm Res 34:64-82
27. Dehdashti AR, Ganna A, Karabatsou K, Gentili F (2008) Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery 62:1006-1015
28. Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T (2010) Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center. Neurosurg Focus 29:E7
29. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526-529
30. Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141-3148
31. Biermasz NR, van Dulken H, Roelfsema F (2000) Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. J Clin Endocrinol Metab 85:4596-4602
32. De P, Rees DA, Davies N, John R, Neal J, Mills RG, Vafidis J, Davies JS, Scanlon MF (2003) Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission. J Clin Endocrinol Metab 88:3567-3572
33. Minniti G, Jaffrain-Rea ML, Esposito V, Santoro A, Tamburrano G, Cantore G (2003) Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature. Endocr Relat Cancer 10:611-619
34. Attanasio R, Montini M, Valota M, Cortesi L, Barbo R, Biroli F, Tonnarelli G, Albizzi M, Testa RM, Pagani G (2008) An audit of treatment outcome in acromegalic patients attending our center at Bergamo, Italy. Pituitary 11:1-11
35. Jane JAJ, Starke RM, Elzoghby MA, Reames DL, Payne SC, Thorner MO, Marshall JC, Laws ERJ, Vance ML (2011) Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. J Clin Endocrinol Metab 96:2732-2740
36. Kreutzer J, Vance ML, Lopes MB, Laws ER Jr (2001) Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab 86:4072-4077
37. Beauregard C, Truong U, Hardy J, Serri O (2003) Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clin Endocrinol (Oxf) 58:86-91
38. Kim MS, Jang HD, Kim OL (2009) Surgical results of growth hormone-secreting pituitary adenoma. J Korean Neurosurg Soc 45:271-274
39. Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ (2010) Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas. Neurosurg Focus 29:E5